EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulatory peptides in barretts esophagus



Regulatory peptides in barretts esophagus



Journal of Pathology 146(3): 227-234



Barrett's epithelium refers to the presence of ectopic mucosal types in the squamous-lined esophagus. Argentaffin and argyrophil-positive cells as well as gastrin-like immunoreactivity were documented in esophageal tissue extracts from patients with Barrett's mucosa. Esophageal (125) biopsies obtained under direct vision at endoscopy from 22 patients wtih Barrett's esophagus were systematically studied using fluorescence and peroxidase antiperoxidase single and double-staining immunocytochemical methods employing highly specific antibodies to localize the following peptide-containing cell types in Barrett's mucosa: gastrin somatostatin, gastric inhibitory polypeptide, motilin, neurotensin and pancreatic glucagon. EC [enterochromaffin] cells were localized using a cytochemical Ag staining method. EC cells and gastrin- and somatostatin-containing endocrine cells are detectable in Barrett's epithelium.

(PDF 0-2 workdays service: $29.90)

Accession: 006292248

Download citation: RISBibTeXText



Related references

Study of p53 gene mutations and serum anti-p53 antibodies in Barretts esophagus and short segment Barretts esophagus. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1319, April, 2000

Quantitative mRNA expression analysis of multiple genes distinguish between Barretts-esophagus and Barretts-associated adenocarcinoma of the esophagus. Proceedings of the American Association for Cancer Research Annual Meeting 43: 464-465, March, 2002

Recurrence of columnar lined esophagus segments after surgery for Barretts associated adenocarcinoma The natural history of Barretts esophagus. Gastroenterology 118(4 Suppl 2 Part 1): A222, April, 2000

The role of retinoid x receptor mrna expression in barretts esophagus and barretts associated adenocarcinoma of the esophagus. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 501, 2003

Racial differences in the prevalence of long segment Barretts esophagus, short segment Barretts esophagus and specialized columnar epithelium at the gastroesophageal junction. Gastroenterology 110(4 SUPPL ): A79, 1996

Curative endoscopic therapy of early cancer and high grade neoplasia in barretts esophagus additional endoscopic ablation of barretts esophagus can reduce the risk of recurrent carcinomas. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No W1270, 2003

Short segment Barretts esophagus Prevalence of Helicobacter pylori infection in comparison to patients with erosive GERD, long segment Barretts esophagus as well as a asymptomatic control group A prospective evaluation. Gastroenterology 118(4 Suppl 2 Part 2): AGA A1303, April, 2000

Analysis of Barretts esophagus causes and risk factors for dysplasia and drug treatment to reverse dysplasia in Barretts esophagus. American Journal of Gastroenterology 98(9 Supplement): S27, September, 2003

Effects of selective pkc epsilon agonist and antagonist short peptides on sustained cellular responses in barretts esophagus. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No W1284, 2003

CD44st and CD44v6 splice variant expression in Barretts esophagus and Barretts adenocarcinoma. Gastroenterology 112(4 SUPPL ): A595, 1997

A multigene expression panel for the molecular diagnosis of Barretts esophagus and Barretts cancers. Gastroenterology 122(4 Suppl 1): A 16-A 17, April, 2002

Expression of trefoil factors in Barretts esophagus, dysplasia and adenocarcinoma arising in Barretts. Laboratory Investigation 82(1): 124A-125A, January, 2002

Is the length of Barretts mucosa related to the prevalence of complications and adenocarcinoma in Barretts esophagus?. Gastroenterology 104(4 SUPPL ): A393, 1993

P53 protein overexpression in Barretts adenocarcinoma and Barretts esophagus in paraffin embedded tissue. Gastroenterology 104(4 SUPPL ): A1045, 1993

Gastric Helicobacter pylori infection is associated with Barretts adenocarcinoma but not Barretts esophagus. Gastroenterology 116(4 PART 2): A319, April, 1999